Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
US5298419A · kind A · utility
7Cited by
3References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 1988 |
| Grant date | Mar 29, 1994 |
| Priority date | — |
| Expiry date | Mar 31, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to the human hybridoma designated MCA 86 and having A.T.C.C. Accession No. HB 9669 and human monoclonal antibodies produced by hybridoma MCA 86. Human monoclonal antibodies produced by hybridoma MCA 86 immunologically binds to both gp41 and gp120 envelope glycoproteins of Human Immunodeficiency Virus (HIV). These monoclonal antibodies are useful in the diagnosis of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.